ATAGI gives green light to Novavax Covid – 19 vaccine

Be the First to Comment Read

ATAGI gives green light to Novavax Covid – 19 vaccine

The Novavax Covid-19 vaccine has been approved by the ATAGI for people aged 18 and above. The vaccine would be available by February. The recommended course for the vaccine will be two doses.

Disclaimer

Speak your Mind

Ad
kalkine logo

GET A FREE STOCK REPORT

Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK